Current & Critical - Deborah Kurrasch, The Biotech Sector in Western Canada

In this episode, I am joined by Deborah Kurrach, UofC Professor Biochemistry & Molecular Biology, CEO & CSO Path Therapeutics, a biotech platform that uncovers new therapeutics and novel druggable targets for diseases of the central nervous system.

Show Notes

There’s plenty of innovation coming out of our start-up community that will transform the way we work. While many are modernizing established industries, Deborah’s innovation just might transform the way our bodies work. That innovation – Path Therapeutics, a biotech platform that uncovers new therapeutics and novel druggable targets for diseases of the central nervous system. Join me as Deborah takes us into Path Therapeutics, her experiences raising funds as an academic and entrepreneur in Calgary, and why education and trusted investments can make Calgary a new, biotech hub.

What is Collisions YYC?

Tired of the same old news cycle? Get informed on what’s happening in businesses in Calgary, Alberta and beyond with Collisions YYC.

Tyler Chisholm hosts Alberta’s best and brightest minds who are shaping the very landscape of our province with their work in fields like Technology, FinTech, Energy, Healthcare, Education, AI, and more. Tyler’s inherent curiosity and exploratory style fuel candid conversations with the people who are driving change in our city, our province and the world.

Connect with us on social media:
https://www.instagram.com/collisionsyyc